FWP

NASDAQ:FWP

Forward Pharma A/S

Stock

USD

Last Close

1.95

27/12 21:00

Volume Today

43.35K

Avg: 9.84K

PE Ratio

151.31

PFCF: -

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21
net income	-19.02M -	-37.00M 94.59%	-33.34M 9.91%	917.09M 2,851.06%	-8.72M 100.95%	-4.22M 51.61%	-6.45M 52.78%	-1.89M 70.66%
depreciation and amortization	3K -	37K 1,133.33%	109K 194.59%	227K 108.26%	4K 98.24%	1K 75%
deferred income tax		466K -	291K 37.55%	-255.45M 87,884.54%
stock based compensation	5.95M -	13.54M 127.54%	14.29M 5.52%	7.08M 50.43%	6.17M 12.88%	2.15M 65.24%	334K 84.43%	1K 99.70%
change in working capital	844K -	-910K 207.82%	5.73M 729.23%	-1.19M 120.70%	-5.42M 357.72%	-89K 98.36%	402K 551.69%	-658K 263.68%
accounts receivables
inventory
accounts payables	2.08M -	3.93M 88.72%	4.20M 6.84%	-1.26M 129.90%	-5.81M 362.42%
other working capital	-1.24M -	-4.84M 290.72%	1.53M 131.52%	71K 95.35%	384K 440.85%
other non cash items	2.76M -	-11.26M 508.16%	-21.18M 88.18%	272.18M 1,384.91%	-6.82M 102.50%	-67K 99.02%		190K -
net cash provided by operating activities	-9.46M -	-35.13M 271.32%	-34.10M 2.91%	939.95M 2,856.04%	-14.79M 101.57%	-2.23M 84.91%	-5.71M 156.07%	-2.36M 58.71%
investments in property plant and equipment	-6K -	-382K 6,266.67%	-31K 91.88%	-3K 90.32%
acquisitions net
purchases of investments	-191.11M -
sales maturities of investments		43.41M -	41.20M 5.09%	85.37M 107.20%
other investing activites	-5K -				3K -		-1K -
net cash used for investing activites	-191.12M -	43.03M 122.51%	41.17M 4.32%	85.36M 107.35%	3K 100.00%		-1K -
debt repayment
common stock issued	220.72M -	155K 99.93%	114K 26.45%	49K 57.02%	1K 97.96%		2K -	3K 50%
common stock repurchased
dividends paid				-1.09B -
other financing activites	16.85M -			-24.81M -	-8.12M 67.27%	-799K 90.16%	-285K 64.33%
net cash used provided by financing activities	237.57M -	155K 99.93%	114K 26.45%	-1.12B 981,407.89%	-8.12M 99.27%	-799K 90.16%	-283K 64.58%	3K 101.06%
effect of forex changes on cash	5.40M -	-1.14M 121.06%	-1.55M 36.20%	145.03M 9,457.10%	-4.11M 102.83%	-1.91M 53.41%	7.49M 491.12%	-5.96M 179.63%
net change in cash	42.39M -	6.92M 83.68%	5.63M 18.66%	51.66M 817.68%	-27.01M 152.29%	-4.94M 81.70%	1.49M 130.12%	-8.32M 658.56%
cash at beginning of period	2.96M -	45.35M 1,434.65%	52.27M 15.26%	57.90M 10.77%	109.55M 89.22%	82.54M 24.66%	77.60M 5.99%	79.09M 1.92%
cash at end of period	45.35M -	52.27M 15.26%	57.90M 10.77%	109.55M 89.22%	82.54M 24.66%	77.60M 5.99%	79.09M 1.92%	70.77M 10.52%
operating cash flow	-9.46M -	-35.13M 271.32%	-34.10M 2.91%	939.95M 2,856.04%	-14.79M 101.57%	-2.23M 84.91%	-5.71M 156.07%	-2.36M 58.71%
capital expenditure	-6K -	-382K 6,266.67%	-31K 91.88%	-3K 90.32%
free cash flow	-9.47M -	-35.51M 275.12%	-34.14M 3.87%	939.94M 2,853.53%	-14.79M 101.57%	-2.23M 84.91%	-5.71M 156.07%	-2.36M 58.71%

All numbers in USD (except ratios and percentages)